An inhalable β2-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung
Authors:
- Xinyun ZhaiXZXinyun Zhai
- Chaonan MaCMChaonan Ma
- Peng SunPSPeng Sun
- Zhiping FuZFZhiping Fu
- Wenguang LiuWLWenguang Liu
- Jun XuJXJun Xu
- 1 August 2012
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 162 (1) , 28-36
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Guanidinylation: A simple way to fabricate cell penetrating peptide analogue‐modified chitosan vector for enhanced gene deliveryJournal of Applied Polymer Science, 2011
- Highly Efficient Gene Silencing Activity of siRNA Embedded in a Nanostructured Gyroid Cubic Lipid MatrixJournal of the American Chemical Society, 2010
- Generation ofmTert-GFP mice as a model to identify and study tissue progenitor cellsProceedings of the National Academy of Sciences, 2008
- Inhalable siRNA: Potential as a Therapeutic Agent in the LungsMolecular Pharmaceutics, 2008
- Nanofibrous membranes from aqueous electrospinning of carboxymethyl chitosanNanotechnology, 2008
- Maximizing DNA Loading on a Range of Gold Nanoparticle SizesAnalytical Chemistry, 2006
- A miniaturized nebulization catheter for improved gene delivery to the mouse lungThe Journal of Gene Medicine, 2005
- Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulizationJournal of Controlled Release, 2004
- 501. Aerosols of Compacted DNA Nanoparticles Retain Structural Integrity and Biological ActivityMolecular Therapy, 2004
- Arginine-rich PeptidesJournal of Biological Chemistry, 2001